- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07419555
벨기에 폐 기능 연구 (AIRCAST)
벨기에 폐기능 연구: 질병 진행의 지표로서의 맞춤형 종단적 폐기능 분석
Currently, it remains unclear how to manage serial lung function measurements in a clinical setting. The investigators aimed to tackle this problem by developing a machine learning (ML) model that can accurately predict population and individual lung function trajectories. These predictions would enable the investigators to identify positive or negative deviations, thereby revealing unexpected disease patterns.
A prospective validation is needed that includes data on mortality, hospitalisations, emergency-room visits and patient-reported outcomes. Within this study, the goal is to validate the ML model with the data collected from this observational study.
연구 개요
상태
정황
상세 설명
The objective of this study is to explore the clinical value of models predicting longitudinal lung function patterns in individuals with chronic respiratory diseases across Belgium.
- The investigators will assess the accuracy of individualised lung function prediction models in a multicentre lung function dataset with prospective clinical and lung function follow-up.
- The investigators will evaluate important health outcomes, step-up in care, patient-reported outcomes in individuals identified with an expected and unexpected observed trajectory as compared to the predicted population and individualised trajectory.
The hypothesis is that patients with an unexpected decline in lung function will have worse health outcomes, such as a higher mortality rate and more hospitalisations, compared to patients with an expected lung function pattern. The investigators hypothesise to observe better health outcomes and lower mortality rates in patients with an unexpectedly positive lung function evolution compared to patients with an expected negative lung function pattern.
Individuals will be recruited from 4 Belgian Hospitals (UZ Leuven, UZ Antwerpen, AZ Delta, ZOL Genk). Based on the annual rate of pulmonary function testing in these hospitals, a sample size of 1.000 participants per centre is anticipated within one year of inclusions, resulting in a total sample size of 4.000 patients.
All available historical lung function data of included individuals will be retrieved from the individuals medical file. Additionally, the individual will be prospectively followed for 2 years where all lung function data will be collected.
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Marieke Wuyts
- 전화번호: 016 34 31 59
- 이메일: marieke.wuyts@kuleuven.be
연구 장소
-
-
-
Edegem, 벨기에, 2650
- 모병
- UZ Antwerpen
-
연락하다:
- Therese Lapperre
- 전화번호: 0032 3 821 5089
- 이메일: therese.lapperre@uza.be
-
수석 연구원:
- Therese Lapperre
-
부수사관:
- Kevin De Soomer
-
Genk, 벨기에, 3600
- 모병
- Ziekenhuis Oost-Limburg
-
연락하다:
- David Ruttens
- 전화번호: 0032 89 80 52 00
- 이메일: david.ruttens@zol.be
-
수석 연구원:
- David Ruttens
-
부수사관:
- Maarten Criel
-
Ghent, 벨기에
- 모병
- UZ Gent
-
수석 연구원:
- Eric Derom
-
연락하다:
- Eric Derom
- 전화번호: 0032 9 332 23 42
- 이메일: Eric.Derom@uzgent.be
-
부수사관:
- Lies Lahousse
-
Leuven, 벨기에, 3000
- 모병
- UZ Leuven
-
수석 연구원:
- Wim Janssens
-
연락하다:
- Marieke Wuyts
- 전화번호: 016 34 31 59
- 이메일: marieke.wuyts@kuleuvne.be
-
Roeselare, 벨기에, 8800
- 모병
- AZ Delta
-
수석 연구원:
- Ingel Demedts
-
연락하다:
- Ingel Demedts
- 전화번호: 0032 51 23 41 16
- 이메일: ingel.demedts@azdelta.be
-
부수사관:
- Bernard Bouckaert
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
Chronic respiratory diseases
설명
Inclusion Criteria:
- Above 18 years old
- Diagnosed with a chronic respiratory disease and followed up in one of the participating Belgian hospitals
- Performed a complete lung function test (spirometry, body plethysmography and diffusion capacity) at baseline
- Have at least 3 historical spirometry measurements over a minimal time window of 2 years prior to inclusion
- Planned routine follow-up within standard clinical care in one of the participating hospitals
Exclusion Criteria:
- Patients who have had a lung transplantation
- Patients not being able to give consent to participate
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: PROSPECTIVE
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Accuracy of lung function predictions (FEV1)
기간: at 1 and 2-year follow-up
|
Proportion of correct and incorrect FEV1 predictions compared to the observed measure |
at 1 and 2-year follow-up
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Differences in clinical outcomes between correct and incorrect lung function predictions (FEV1)
기간: at 1 and 2-year follow-up
|
Differences between patients with correct and incorrect individual lung function predictions for FEV1 on clinical endpoints (such as mortality, hospitalisations, frailty, health status and step-up in care |
at 1 and 2-year follow-up
|
|
Accuracy of lung function predictions
기간: at 1 and 2-year follow-up
|
Proportion of correct and incorrect lung function predictions (FVC, TLC, RV/TLC, DLCO) compared to the observed measure |
at 1 and 2-year follow-up
|
|
Differences in clinical outcomes between correct and incorrect lung function predictions
기간: at 1 and 2-year follow-up
|
Differences between patients with correct and incorrect individual lung function predictions for FVC, TLC, RV/TLC, DLCO on clinical endpoints (such as mortality, hospitalisations, frailty, health status and step-up in care) |
at 1 and 2-year follow-up
|
|
Identifying the minimal needed to make predictions
기간: after 2 years
|
Minimal number of tests/length of follow-up required for optimal predictions |
after 2 years
|
|
Performance of ML-based predictions compared to linear regression analysis
기간: at 1 and 2-year follow-up
|
Comparison of the ML-based predictions for individual and population lung function changes with predictions based on linear regression on individual historical data |
at 1 and 2-year follow-up
|
|
Overall description of population
기간: baseline, 1 and 2-year follow-up
|
Sociodemographic information, health status, comorbidities, frailty, disease labels, interventions and prognosis of individuals with a chronic respiratory disease |
baseline, 1 and 2-year follow-up
|
공동 작업자 및 조사자
스폰서
협력자
수사관
- 수석 연구원: Wim Janssens, UZ/KU Leuven
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .